(Press-News.org) A new computational method for working out in advance whether a chemical will be toxic will be reporting in a forthcoming issue of the International Journal of Data Mining and Bioinformatics.
There is increasing pressure on the chemical and related industries to ensure that their products comply with increasing numbers of safety regulations. Providing regulators, intermediary users and consumers with all the necessary information to allow them to make informed choices with respect to use, disposal, recycling, environmental issues and human health issues is critical. Now, Meenakshi Mishra, Hongliang Fei and Jun Huan of the University of Kansas, in Lawrence, have developed a computational technique that could allow the industry to predict whether a given compound will be toxic even at a low dose and thus allow alternatives to be found when necessary.
Toxicity is almost always an issue of availability and dosage. Whether or not a compound is natural or synthetic it can be toxic from snake venom and jellyfish stings to petrochemicals and pesticides. However, some chemicals are more toxic than others, exposure to a lower dose will cause health problems or potentially be lethal. It is very important to find a way to determine whether a newly discovered synthetic or natural chemical might cause toxicity problems.
The team also points out that the US Environmental Protection Agency (EPA) and the Office of Toxic Substances (OTS) in the USA had listed 70,000 industrial chemicals in the 1990s, with 1000 chemicals added each year for which even simple toxicological experiments had not been carried out. This is largely a problem of logistics and costs as well as the ethical question of whether so many tests, which would have to be carried out on laboratory animals, should be done at all.
Now, Huan and colleagues in the Department of Electrical Engineering and Computer Science at Kansas, have successfully tested a statistical algorithm against more than 300 chemicals for which the toxicity profile is already known. Their technique offers a computational method of screening a large number of compounds for obvious toxicity very quickly and might preclude the need for animal testing of the compounds, provided regulators don't insist on such "in vivo" data from the latter.
The research builds on well-established principles from the pharmaceutical industry known as Quantitative structure-activity relationships (QSARs) in which the type of atoms and how they are connected together can be correlated with the activity of a drug molecule. Certain molecular shapes and types are soluble in water, for instance, or interact in a certain way with different enzymes and other proteins in the body, leading to their overall activity. Different molecular features will make a similar molecule behave in a different way - more or less soluble, stronger or weaker acting. The team has now turned the QSAR around so that instead of searching for the features in a molecule that make it of benefit in medicine they look for the atomic groups and the type of bonds that hold them together to find associations with toxicity.
The team points out that few earlier attempts at predicting toxicity of chemicals have proved successful, most approaches are no better than random guessing. The team's new statistical approach combines "Random Forest" selection with "Naïve Bayes" statistical analysis to boost the predictions well beyond random. They team saw prediction accuracy in 2 out of 3 chemicals tested. Given that there are around 100,000 industrial chemicals that need toxicity profiling, this result should allow the industry and regulators to focus on a large number of the most pressing of those, the ones predicted to have greatest toxicity and leave the less likely until additional resources are available.
The researchers are now tuning the algorithm to work faster and with greater precision so that it ignores common molecular features now known not to contribute to toxicity characteristics in the chemicals they have studied so far.
###
"Computational prediction of toxicity" in Int. J. Data Mining and Bioinformatics, 2013, 8, 338-348
Computing toxic chemicals
We know that you're toxic
2013-07-18
ELSE PRESS RELEASES FROM THIS DATE:
Optimal irradiation dose and time window of local X-ray for spinal cord injury
2013-07-18
The glial scar is the main inhibitor of axon regeneration and functional recovery in the central nervous system. Appropriate dose X-ray irradiation has been shown to inhibit the formation of glial cells, thereby promoting axonal regeneration. In addition, X-rays militate against the death and degeneration of neurons, and improve the recovery of locomotor function following spinal cord injury. However, the optimal treatment time window and dose of X-irradiation for spinal cord injury is still unknown. Prof. Shiqing Feng and colleagues from Tianjin Medical University have ...
Early detection and treatment of Alzheimer's disease prevents psychological and behavioral symptoms
2013-07-18
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.
The study followed persons with Alzheimer's disease over a course of three years. The study participants were diagnosed either at the very mild or mild phase of the disease and treated within the standard healthcare system.
According to the study, persons with a very ...
Irish potato famine-causing pathogen even more virulent now
2013-07-18
The plant pathogen that caused the Irish potato famine in the 1840s lives on today with a different genetic blueprint and an even larger arsenal of weaponry to harm and kill plants.
In a study published in the journal Nature Communications, North Carolina State University plant pathologist Jean Ristaino and colleagues Mike Martin and Tom Gilbert from the University of Copenhagen compared the genomes, or sets of all genes, of five 19th century strains of the Phytophthora infestans pathogen with modern strains of the pathogen, which still wreaks havoc on potatoes and tomatoes.
The ...
Moderate dose radiotherapy effective in EORTC trial for patients with desmoid-type fibromatosis
2013-07-18
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
Dr. Ronald B. Keus, Arnhem Radiotherapy Institute in The Netherlands and Coordinator of this study says, "Although one should still be cautious to use radiotherapy in these young patients, it is important to have shown ...
New methods to visualize bacterial cell-to-cell communication
2013-07-18
Most bacteria are able to communicate with each other by secreting signaling molecules. Once the concentration of signals has reached a critical density («the Quorum), the bacteria are able to coordinate their behavior. Only when this critical population density has been reached certain genes are activated that lead to, for example, the formation of biofilms or the expression of virulence factors. Bacteria utilize this so-called «Quorum Sensing» (QS) to synchronize their behavior to regulate functions that benefit the entire population.
The most commonly used signaling ...
Study demonstrates link between reclassification of cannabis and cannabis psychosis
2013-07-18
Researchers from the University of York have demonstrated that the change in cannabis declassification in 2009 has coincided with a significant increase in hospital admissions for cannabis psychosis - rather than the decrease it was intended to produce.
The UK Misuse of Drugs Act (1971) divided controlled drugs into three groups – A, B and C – with descending criminal sanctions attached to each class. Cannabis was originally assigned to Group B, but in 2004, it was transferred to the lowest risk group, Group C.
In 2009, on the basis of increasing concerns about a link ...
Spanish scientists successfully generate 'artificial bones' from umbilical cord stem cells
2013-07-18
Scientists in Granada, Spain, have patented a new biomaterial that facilitates generating bone tissue—artificial bones in other words—from umbilical cord stem cells . The material, consisting of an activated carbon cloth support for cells that differentiate giving rise to a product that can promote bone growth, has recently been presented at a press conference at the Biomedical Research Centre, Granada.
Although the method has not yet been applied with 'in vivo' models, laboratory results are highly promising. In the future, they could help manufacture medicines for the ...
Newly found CLAMP protein regulates genes
2013-07-18
PROVIDENCE, R.I. [Brown University] — They say a good man is hard to find. Were it not for a newly discovered protein, the X chromosome of a male fruit fly could never be found by a gene-regulating complex that male flies need to develop and survive. And that case is just one example of what the new finding means. More generally, the research provides biologists with a model of how proteins that govern gene transcription find their targets on chromosomes, a process that's essential to healthy cell function and sometimes implicated in disease.
The new protein, dubbed CLAMP ...
Milikelvins drive droplet evaporation
2013-07-18
Evaporation is so common that everybody thinks it's a well understood phenomenon. Appearances can be, however, deceptive. Recently, a new, earlier not predicted mechanism of evaporation was discovered. Experiments and simulations performed at the Institute of Physical Chemistry of the Polish Academy of Sciences and the Institute of Physics of the PAS not only confirm its existence, but also indicate that it plays the crucial role in evaporation process in the nanoscale.
Too hot? It's not only because of summer. It's also likely that the sweat on your skin stopped to evaporate ...
Biochemical mapping helps explain who will respond to antidepressants
2013-07-18
DURHAM, N.C. -- Duke Medicine researchers have identified biochemical changes in people taking antidepressants – but only in those whose depression improves. These changes occur in a neurotransmitter pathway that is connected to the pineal gland, the part of the endocrine system that controls the sleep cycle, suggesting an added link between sleep, depression and treatment outcomes.
The study, published on July 17, 2013, in the journal PLOS ONE, uses an emerging science called pharmacometabolomics to measure and map hundreds of chemicals in the blood in order to define ...
LAST 30 PRESS RELEASES:
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
Dose of psilocybin, dash of rabies point to treatment for depression
Helping health care providers navigate social, political, and legal barriers to patient care
Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments
Using smartphones to improve disaster search and rescue
Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing
Ultrafast material captures toxic PFAS at record speed and capacity
Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli
UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections
OYE Therapeutics closes $5M convertible note round, advancing toward clinical development
Membrane ‘neighborhood’ helps transporter protein regulate cell signaling
Naval aviator turned NPS doctoral student earns national recognition for applied quantum research
Astronomers watch stars explode in real time through new images
Carbon-negative building material developed at Worcester Polytechnic Institute published in matter
[Press-News.org] Computing toxic chemicalsWe know that you're toxic